ICUI

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About ICU Medical, Inc.

ICU Medical, Inc. develops, manufactures and sells innovative medical products used in infusion therapy and critical care applications. ICU Medical's product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. ICU Medical is headquartered in San Clemente, California.
CEO
Vivek Jain
Employees
7900
Headquarters

951 Calle Amanecer
San Clemente, California 92673-6212
Phone: 19493662183
www.icumed.com

News

ICU Medical downgraded to market perform at Raymond James on negative macro environment
Nov 08, 2022 14:53pm

Raymond James has downgraded ICU Medical to market perform from outperform citing a challenging macro environment such as foreign exchange rates and supply chain-related cost pressures.


Source:Seeking Alpha
ICU Medical, Inc. 2022 Q3 - Results - Earnings Call Presentation (NASDAQ:ICUI)
Nov 08, 2022 07:56am

The following slide deck was published by ICU Medical, Inc.


Source:Seeking Alpha
ICU Medical, Inc. (ICUI) Q3 2022 Earnings Call Transcript
Nov 08, 2022 05:42am

ICU Medical, Inc. (NASDAQ:NASDAQ:ICUI) Q3 2022 Earnings Conference Call November 07, 2022, 17:00 ET Company Participants John Mills - ICR Vivek Jain - CEO & Chairman Brian Bonnell - CFO…


Source:Seeking Alpha
ICU Medical Announces Third Quarter 2022 Results
Nov 07, 2022 21:05pm

The Company Reaffirms 2022 Fiscal Year Guidance The Company Reaffirms 2022 Fiscal Year Guidance


Source:GlobeNewswire
ICU Medical Q3 2022 Earnings Preview (NASDAQ:ICUI)
Nov 07, 2022 05:40am

ICU Medical (ICUI) is scheduled to announce Q3 earnings results on Monday, November 7th, after market close.The consensus EPS Estimate is $1.46 (-29.5% Y/Y) and the consensus…


Source:Seeking Alpha
US FDA warns of tracheostomy tube shortage
Oct 31, 2022 20:54pm

US Food and Drug Administration (FDA) said on Monday (Oct 31) there was a shortage of tracheostomy tubes, a surgical device that helps patients to breathe, including those manufactured by ICU Medical. The agency said the shortage was due to difficulties in raw material procurement and would most likely imp


Source:Channel NewsAsia
IV Bags Market is Likely to Rise at a CAGR of 5.8% from 2020 - 2032, TMR Study
Oct 13, 2022 08:33am

WILMINGTON, DE / ACCESSWIRE / October 13, 2022 / Transparency Market Research Inc. - IV bags are a key product segment in the field of parenteral packaging and are assisting in supplying plastic materials, needed for intravenous therapy at healthcare infrastructure units such as hospitals and clinics. Key factors behind the increasing demand for IV bags in parenteral packaging are ease of product availability and cost-effective nature. Prominent IV bags market players are making huge investments in research and development undertakings such as establishing R&D centers that function to manufacture improved IV bags that would requirements of patients suffering from different diseases. IV bags have also displayed high efficiency in the accurate delivery of medication to blood veins through the transfusion process. With healthcare facilities becoming accessible in remote locations, IV bags could witness increased demand during the assessment period, which could help grow the market. New IV bags launch is helping leading players in generating large amounts of revenue and assisting the players in gaining an edge over competitors.


Source:Accesswire
ICU Medical Announces Time of Third Quarter 2022 Earnings Conference Call
Oct 06, 2022 12:30pm

SAN CLEMENTE, Calif., Oct. 06, 2022 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2022 earnings release and conference call.


Source:GlobeNewswire